arrow
E

E. Underwood

AstraZeneca
H指数:13
被引数:2,717

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of 6-Fluoro-5-{4-[(5-fluoro-2-methyl-3-oxo-3,4-dihydroquinoxalin-6-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD9574): A CNS-Penetrant, PARP1-Selective Inhibitor
2024-12-100
PRE
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
2024-07-310
PRE
Identification of Novel Potent NSD2-PWWP1 Ligands Using Structure-Based Design and Computational Approaches
2024-05-154
PRE
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs
2021-09-2781
PREAI
Fragment-Based Design of a Potent MAT2a Inhibitor and in Vivo Evaluation in an MTAP Null Xenograft Model
2021-04-2628
OAAI
Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy
2021-03-0818
PREAI
A head-to-head comparison of the properties of five clinical PARP inhibitors identifies new insights that can explain both the observed clinical efficacy and safety profiles
2018-07-0120
PRE
Focused Structure-Based Virtual Screening Identifies Novel Inhibitors of SOS1

基于结构的虚拟筛选发现SOS1的新型抑制剂

0
PRE
Structural and Molecular Insight into the PWWP1 Domain of NSD2 from the Discovery of Novel Binders Via DNA-Encoded Library Screening

通过DNA编码库筛选发现新型结合物,揭示NSD2的PWWP1结构域的结构与分子机制

0
OA